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Exposure of a human lung epithelial cancer cell-line to hypo-osmotic media led to a marked increase in the rate of et&x from the cells of taurine, 
a non-essential sulfonic amino acid. The osmotically-activated taurine efllux was inhibited by a range of known Cl- channel blockers, the most 
potent of which were NPPB and 1,9-dideoxyforskolin. These reagents were similarly effective at inhibiting the osmotically-activated flhtx of I-, 
a known substrate of volume-activated Cl- channels. The results are consistent with the hypothesis that volume-regulatory taurine release from 
these cells is mediated by a volume-activated Cl- channel. 
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1. INTRODUCTION 
Most cell-types have the ability to regulate their vol- 
ume following cell swelling. An increase in cell volume 
triggers the activation of membrane transport pathways 
which mediate the net et&x of cytoplasmic solutes; this 
results in the cell undergoing a regulatory volume de- 
crease (RVD). Most studies of RVD mechanisms have 
focused on the role of K+ and Cl-, which escape from 
the cell via separate volume-activated channels and/or 
a volume-activated KC1 cotransporter [ 1,2]. However, 
many cells, when swollen, also release small organic 
solutes and this process often makes a substantial con- 
tribution to the total RVD. In vertebrate cells the pri- 
mary organic ‘osmolyte’ is usually tam-me, a sulfonic 
amino acid which may be present in the cytoplasm at 
concentrations of up to 40 mM [3]. Volume-activated 
taurine release has been demonstrated from many verte- 
brate cells and tissues including fish erythrocytes, heart, 
brain and hepatocytes [4-121, bird erythrocytes [13], 
Ehrlich ascites tumour cells [14-163, MDCK cells 
[17,18], rabbit lymphocytes [19], and a variety of mam- 
malian brain cell-types [20-241. These studies have re- 
vealed a number of common characteristics for the 
transport mechanisms which mediate volume-activated 
taurine release from different cells: they are, in general, 
Na’-independent, non-saturable and not prone to 
‘trans-stimulation’ [6,1.5,18,22,25]. In many cases vol- 
ume-activated taurine et&x is accompanied by the re- 
lease of other amino acids including glutamate, aspar- 
tate, j?-alanine and glycine [ l&17,1 8,211, suggesting that 
the pathways are not highly selective. However there is 
evidence that they have a relatively low permeability to 
cationic amino acids [6,18]. 
Amino acids are not the only organic osmolytes used 
by mammalian cells. On prolonged exposure to hyper- 
osmotic media a number of mammalian renal and brain 
cell-types accumulate high concentrations of polyols, 
predominantly sorbitol and inositol [2629]. When re- 
turned to iso-osmotic solution the cells swell and re- 
spond by releasing these compounds, thereby undergo- 
ing RVD [26,29-341. The volume-activated sorbitol and 
inositol transport mechanisms are Na’-independent 
and non-saturable [30,34]. They accommodate a num- 
ber of different polyols [30] and show pharmacological 
similarities to the pathways which mediate volume-reg- 
ulatory amino acid release from other cell-types [34]. 
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In a recent study of fish (flounder) erythrocytes we 
obtained data consistent with the hypothesis that the 
volume-activated taurine transport pathway in these 
cells is permeable to the monosaccharide glucose and to 
the nucleoside uridine [25]. The very broad substrate 
specificity of this pathway, its Na’-independence and its 
failure to saturate or to show trans-stimulation suggest 
that it behaves less like a conventional amino acid trans- 
porter than a pore or channel. The pharmacological 
properties of this pathway are very similar to those of 
‘Cl- channels’ in other cells [25] and it has recently 
proposed that the volume-regulatory et&x of amino 
acids and of other organic osmolytes from a number of 
different cell-types is via channels of this sort [l&34,35]. 
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In the work reported here we have demonstrated vol- 
ume-activated taurine release from a human epithelial 
lung cancer cell line, and have made a direct comparison 
of the pharmacological properties of the taurine path- 
way with those of a pathway which mediates the swel- 
ling-activated release of I-, a known substrate of vol- 
ume-activated Cl- channels. The results further support 
the hypothesis that volume-activated Cl- channels me- 
diate the transport of small organic solutes and that this 
represents an important aspect of their physiological 
function. 
2. MATERIALS AND METHODS 
2.1. Materials 
Cell culture reagents were from ICN Biomedicals. [14C]Taurine was 
from DuPont New England Nuclear. 1,9-Dideoxyforskolin, gliben- 
clamide, verapamil, quinine and 4,4’-diisothiocyanatostilbene-2,2’- 
disulfonic acid (DIDS) were from Sigma and 5-nitro-2-(3-phenylpro- 
pylamino) benzoic acid (NPPB) was a generous gift from Prof. R. 
Greger (Physiologisches Institut der Albert-Ludwigs-Universitat, 
Freiburg, Germany). All inhibitors were made up as stock solutions 
(60 mM) in dimethyl sulfoxide. 
2.2. Cell culture 
The human lung epithelial cancer cell line, Sl [36], was maintained 
as a monolayer culture in HAMS F12 medium supplemented with 10% 
v/v fetal calf serum and 2 mM glutamine. Cells were grown in 5% CO2 
under 100% humidity at 37°C and maintained in exponential growth 
phase by passaging twice weekly. Exponentially growing cells were 
trypsinised, centrifuged and resuspended infresh growth medium. Cell 
suspension (2 ml) was aliquoted into 35 mm diameter tissue culture 
dishes and allowed to grow to 60-901 confluence. 
2.3. Solutions 
EfIIux of taurine and I- from Sl cells was measured under both 
iso-osmotic and hypo-osmotic onditions. In the initial taurine efllux 
experiments the iso-osmotic solution contained 150 mM NaCl, 5 mM 
KCl, 1.3 mM CaCl,, 0.5 mM MgCI,, 10 mM HEPES and 5 mM 
glucose and was pa-adjusted to 7.4. In the hypo-osmotic solution the 
NaCl concentration was reduced to 95 mM, while the other compo- 
nents remained unchanged. Later taurine eflux experiments were 
carried out in solutions designed to minimise the ability of the cells to 
undergo RVD in the hypo-osmotic media. In these experiments the 
iso-osmotic solution contained 55 mM NaCI, 85 mM KCl, 25 mM 
taurine, 1.3 mM CaCl,, 0.5 mM MgCl,, 10 mM HEPES and 5 mM 
glucose and was pH-adjusted to 7.4. In the hypo-osmotic solution 
NaCl was omitted, while the other components remained unchanged. 
I- efIIux was monitored using an I--sensitive electrode (HNU sys- 
tems, USA); these experiments were therefore carried out using halide- 
free solutions in order to minimise interference with the I- measure- 
ments. The iso-osmotic solution contained 150 mM NaN09, 5 mM 
KNOs, 1.3 mM Ca(NO,),, 0.5 mM Mg(NO&, 10 mM HEPES and 
5 mM glucose and was pH-adjusted to 7.4. In the hypo-osmotic solu- 
tion the NaNO, concentration was reduced to 95 mM, while the other 
components remained unchanged. 
The osmolality of the solutions was measured using a freezing-point 
osmometer (Roebling, Germany). The osmolality of the iso-osmotic 
solutions was, in all cases, within the range 295-310 mosm . kg-‘, and 
that of the hypo-osmotic solutions, in all cases, within the range 
200-210 mosm . kg-‘. 
2.4. Taurine efpU 
Cells grown to 60-90% confluence in 35 mm diameter dishes were 
loaded with [L4C]taurine by incubation for l-3 h at 37’C in standard 
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growth medium (1 ml) containing [14C]taurine at an activity of 0.1 pCi/ 
ml. [14C]Taurine efflux was measured at room temperature (-22°C). 
Immediately before beginning each efflux experiment the loading solu- 
tion was removed and the cells were washed (6-10 times) by the 
repeated addition then removal of 1 ml of iso-osmotic saline, over a 
48 min period. Wash solutions were discarded. On removal of the 
final wash a further 1 ml of iso-osmotic solution was added to the dish. 
After either 1 or 2 min the solution was removed and replaced imme- 
diately with another 1 ml aliquot. The solution removed from the 
culture dish was transferred irectly to a scintillation vial containing 
2 ml of scintillant. This procedure was repeated throughout he dura- 
tion of the experiment, with the iso-osmotic solution being replaced 
with solutions of different composition as required. On completion of 
the time-course, 1 ml of 0.5 M NaOH was added to each dish to lyse 
the cells and thereby release the remaining intracellular taurine. After 
5 min the lysate was transferred to a scintillation vial and the dish 
rinsed (x5) with 1 ml aliquots of H,O which were also transferred to 
vials for /J-scintillation counting. 
Taurine eflIux time-courses were analysed by plotting ln(Taurine,(t)/ 
Taurine,(t = 0)) versus time, t. Taurine,(t = 0) denotes the total amount 
of [14C]taurine present inside the cells at the beginning of the efllux 
time-course and was obtained by summing the amount of radioactivity 
(dpm) in all of the samples taken throughout he time-course together 
with that remaining in the NaOH cell extracts and H,O rinses. Tau- 
r&e,(t) denotes the amount of [14C]taurine r maining inside the cells 
at time t and was obtained by subtracting the sum of the radioactivity 
in the samples taken up to time t from the total amount originally 
present inside the cells. The negative slope of the graph of ln(Tau- 
rine,(t)lTaurine,(t = 0)) versus t provides a measure of the unidirec- 
tional rate constant for taurine efflux. 
2.5. Iodide efflux 
Cells grown to 6@90% confluence in 35 mm diameter dishes were 
loaded with I- by incubation for l-2 h at 37°C in a solution (1 ml) 
comprised of 140 mM NaI, 5 mM KI, 1.3 mM Ca(NO,),, 0.5 mM 
Mg(NO&, 20 mM HEPES and 5 mM glucose and supplemented with 
20% v/v fetal calf serum. I- eftlux experiment were carried out at room 
temperature using a protocol very similar to that used in the [14C]tau- 
rine experiments. The loading solution was removed and the cells 
washed (x6) in iso-osmotic (halide-free) solution before commencing 
the e&x time-course with the addition of a further 1 ml aliquot of 
solution. At 1 min intervals the solution was removed and immediately 
replaced with another 1 ml aliquot, with the composition of the added 
solution being altered as required. The solutions removed from the 
culture dish were, for convenience, transferred to 24-well plates and 
the I- concentration in each subsequently measured using an I--sensi- 
tive electrode. 
At the conclusion of the I- efAux time-courses a 1 ml aliquot of 
hypo-osmotic halide-free saline was added to the cells and left for at 
least 1 h before being transferred to the 24 well plate and replaced with 
another 1 ml aliquot of hypo-osmotic saline. This was repeated twice 
then the dishes rinsed twice more with 1 ml aliquots of hypo-osmotic 
saline. The I- present in the three final (>l h) incubation samples, 
together with that in the final rinse solutions provided a measure of 
the total free (diffusible) I- remaining in the cells at the conclusion of 
the time-course xperiment. 
I- efflux time-courses were analysed by plotting ln(Z;(f)/Z;(t = 0)) 
versus time, 1. Z;(t = 0) denotes the total diffusible I- present inside the 
cells at the beginning of the efllux time-course and was obtained by 
summing the concentration of I- in each of the 1 ml samples taken 
throughout the time-course, together with that in the final (>l h) 
incubation samples and rinse solutions. Z;(t) denotes the amount of I- 
remaining inside the cells at time t and was obtained by subtracting 
the sum of the I- concentrations in the samples taken up to time t from 
the total amount of I- originally present inside the cells. The negative 
slope of the graph of ln(Z;(t)/Z;(t = 0)) versus t provides a measure of 
the unidirectional rate constant for I- efflux. 
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3. RESULTS 
Fig. 1 shows the effect of extracellular osmolality on 
the time-course for efflux of [‘4C]taurine from Sl cells. 
The cells were bathed initially in iso-osmotic solution 
which, at the point indicated, was replaced by hypo- 
osmotic solution containing 95 mM NaCl. Following 
the exposure of cells to this solution there was a short 
(2-3 min) lag, followed by a marked increase in the 
taurine et&x rate. The osmotic activation of taurine 
efllux was readily reversible; on replacement of the 
hypo-osmotic solution with the original iso-osmotic me- 
dium the efllux reverted to its original value. On return 
of the cells to hypo-osmotic media, taurine et&x again 
increased after a short lag; however, the rate of influx 
was less than that following the initial hypo-osmotic 
exposure. When the cells were returned to the iso- 
osmotic solution the flux again reverted to its original 
level and on subsequent exposure of the cells to hypo- 
osmotic solution the rate of taurine efflux increased 
only slightly. 
Fig. 2 illustrates the effect of the composition of the 
hypo-osmotic solution on the rate of decline of the tau- 
rine et&x rate constant following hypotonic exposure. 
On prolonged incubation of the cells in a hypo-osmotic 
solution containing Na+ as the primary cation the tau- 
rine efllux rate gradually decreased, returning to its 
original value, usually within 40 to 80 min (Fig. 2, 
closed symbols). A different pattern of behaviour was 
seen for cells exposed to a hypo-osmotic solution con- 
taining KC1 (85 mM) + taurine (25 mM) in place of 
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Fig. 1. Effect of medium osmolality on the efllux of taurine from Sl 
cells. The graph shows the In of the fraction of original intracellular 
taurine remaining as a function of time; the negative slope of the line 
is therefore equivalent o the unidirectional efflux rate constant. The 
bathing medium was alternated between iso-osmotic solution 
(150 mM NaCl, 5 mM KCI, 1.3 mM CaCl*, 0.5 mM MgCl,, 20 mM 
HEPES, 5 mM glucose; pH 7.4) and hypo-osmotic solution (in which 
NaCl was reduced to 95 mM) as indicated. The data are from a single 
experiment and are representative of those obtained in five similar 
experiments with different cell preparations. 
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Fig. 2. Effect of the composition of the extracellular medium on the 
osmotically-activated efflux of taurine from Sl cells. The cells were 
bathed initially in iso-osmotic medium which, at the point indicated 
(t = 5 min) was replaced with hypo-osmotic medium. In the time- 
course represented by the closed circles the iso- and hypo-osmotic 
media were as for Fig. 1. In the time-courses represented by the open 
circles the composition of the media was altered to minimise the ability 
of the cells to undergo RVD following hypotonic swelling; the iso- 
osmotic solution contained 55 mM NaCl, 85 mM KCl, 25 mM taurine, 
1.3 mM CaCl,, 0.5 mM MgCl,, 20 mM HEPES and 5 mM glucose (PH 
7.4), while in the hypo-osmotic solution NaCl was omitted. The data 
shown are from a single experiment and are representative of those 
obtained in three similar experiments with different cell preparations. 
NaCl (Fig. 2, open circles). For cells in this solution the 
(normally outward) electrochemical gradients for K’ 
and taurine were reduced or even reversed and the cells 
were therefore prevented from undergoing RVD (e.g. 
[lo]). Under these conditions the initial increase in the 
rate of taurine etllux following the reduction in osmola- 
lity was approximately the same as that seen in the 
low-K’ medium; however the enhanced efllux rate per- 
sisted for very much longer and had not returned to 
basal levels even after 2 h. 
All subsequent experiments were carried out using 
the high-K’/taurine solution in order to prolong the 
osmotically-activated response. In repeated experi- 
ments, carried out under these conditions the taurine 
efTlux rate constant increased, on average, from 
0.37 + 0.06 h-’ ( f S.E.M., n = 15) in isotonic media 
(295-310 mosm * kg-‘) to 4.0 f 0.9 h-l (n = 15) in hypo- 
tonic media (20&210 mosm . kg-‘), an increase of more 
than IO-fold. 
A variety of known Cl- channel blockers were tested 
for their effect on osmotically-activated taurine release 
(Table I). 1,9-Dideoxyforskolin, recently identified as 
an effective inhibitor of the osmotically-activated Cl- 
channel associated with the human mdrl gene product, 
P-glycoprotein [37,38], was a potent inhibitor of osmoti- 
cally-activated taurine efflux. Other P-glycoprotein in- 
hibitors, verapamil and quinine, were somewhat less 
effective, as was glibenclamide, a recently identified in- 
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Fig. 3. Reversible inhibition of osmotically-activated taurine efllux by 
1,9dideoxyforskolin and NPPB. The cells were bathed initially in 
iso-osmotic (high K+/taurine) medium which, at the point indicated 
(t = 5 min), was replaced with hypo-osmotic solution containing either 
0.1 mM 1,9-dideoxyforskolin (w), 0.1 mM NPPB (& or no inhibitor 
(0). At t = 15 min the 1,9-dideoxyforskolin and NPPB solutions were 
replaced with inhibitor-free (hypo-osmotic) medium. 
hibitor of the cystic fibrosis transmembrane conduct- 
ance regulator, CFTR (not shown) [39]. The more 
widely recognised chloride channel blockers NPPB and 
DIDS [40] also blocked osmotically-activated taurine 
release, though with lesser potency than 1,9-dide- 
oxyforskolin. The inhibitory effects of all of the block- 
ers tested were fully reversible. Fig. 3 shows representa- 
tive time-course xperiments, illustrating the inhibitory 
effect and reversibility of the two most potent inhibitors 
identified, 1,9-dideoxyforskolin and NPPB, on osmoti- 
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Fig. 4. Osmotically-activated I- efllux from Sl cells. The graph shows 
the In of the fraction of original intracellular I- remaining as a function 
of time; the negative slope of the line is therefore equivalent o the 
unidirectional I- efflux rate constant. The cells were bathed initially 
in iso-osmotic medium (150 mM NaN09, 5 mM KN03, 1.3 mM 
Ca(NO,),, 0.5 mM Mg(NO& 20 mM HEPES, 5 mM glucose; pH 7.4) 
which, at the point indicated (t = 5 min), was replaced with hypo- 
osmotic solution (in which NaNO, was reduced to 95 mM) containing 
either 0.1 mM 1,9-dideoxyforskolin (w), 0.1 mM NPPB (A) or no 
inhibitor (0). 
tally-activated taurine release from cells in a high K’/ 
tam-me medium. 
The pathway mediating osmotically-activated taurine 
release from Sl cells showed pharmacological charac- 
teristics very similar to those of volume-activated Cl- 
channels in other cell-types. In order to confirm the 
presence of such channels in these cells, and to make a 
quantitative comparison between the pharmacological 
properties of these channels and those of the taurine 
release pathway, we measured the efAux of I- under 
iso-osmotic and hypo-osmotic conditions. I- is a useful 
congener for Cl- in the study of volume-activated Cl- 
channels as such channels show a higher permeability 
to I- than to Cl- itself, whereas I- is a poor substrate 
for anion exchange mechanisms and cation-anion 
cotransporters [41]. 
Fig. 4 shows representative time-courses for the et&x 
of I- from S 1 cells. On reduction of the osmolality of the 
extracellular solution there was, after a short lag, a 
marked increase in the rate of I- efhux. On average the 
I- efIlux rate constant increased from 3.1 + 0.5 h-’ 
(n = 14) under isotonic conditions to 10.1 f 1.2 h-’ 
(n = 14) in hypotonic media. Osmotically-activated I-
release was inhibited by NPPB and by 1,9-dide- 
oxyforskolin: 0.1 mM NPPB reduced osmotically-acti- 
vated I- efilux to 52 f 9% its control value (n = 8); 0.1 
mM 1,9-dideoxyforskolin was more effective, reducing 
the osmotically-activated I- et&x to 11 z!z 4% its con- 
trol value (n = 10). Neither inhibitor had any significant 
effect on I- efllux from cells under iso-osmotic condi- 
tions (not shown). The percentage inhibition of osmoti- 
cally-activated I- etllux by 0.1 mM NPPB and by 0.1 
mM 1,9-dideoxyforskolin was not significantly different 
from that of osmotically-activated taurine etllux 
(P > 0.05, paired t-test). 
Fig. 5 shows dose-response curves for the effect of 
1,9-dideoxyforskolin on the osmotically-activated com- 
ponents of taurine and I- et&x. The two curves are 
superimposable, with an IC,, value of 63 f 5 ,uM for 
taurine and 59 f 6 ,uM for II. There was no significant 
difference (P > 0.05, paired t-test) between the mean 
Table I 
Effect of Cl- channel blockers (0.1 mM) on osmotically-activated 
taurine etllux from Sl cells. The osmotically-activated flIux compo- 
nent was calculated by subtracting the rate constant for taurine efilux 
in iso-osmotic medium from the maximum rate constant attained 
following reduction of the osmolality and is expressed as a percentage 
of that measured in the absence of inhibitors. The data are averaged 
from 4-10 experiments imilar to those illustrated in Fig. 3. 
Inhibitor Volume-activated taurine efflux 
(8 of control) 
Quinine 
Verapamil 
DIDS 
NPPB 
1,9-Dideoxyforskolin 
80 + 7 (n = 4) 
76 f 6 (n = 5) 
61 + 5 (n = 5) 
39 +_ 7 (?I = 8) 
19 f 4 (n = 10) 
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IC,, values for the two substrates, nor between the per- 
centage inhibition of the volume-activated fluxes of the 
two substrates at any of the inhibitor concentrations 
tested. The pharmacological data are therefore consis- 
tent with the hypothesis that osmotically-activated ef- 
flux of taurine and I- from these cells was via a common 
pathway. 
4. DISCUSSION 
Exposure of mammalian cells to hypo-osmotic media 
causes them to swell. Osmotic swelling of human lung 
epithelial cancer (Sl) cells was shown here to result in 
the activation of a pathway which mediated the ehlux 
of the non-essential sulfonic amino acid, taurine. In this 
respect Sl cells resemble a wide variety of other mam- 
malian cell-types including epithelial [ 17,181, brain 
[20,22,24] and blood [19] cells, as well as numerous 
lower vertebrate and marine invertebrate cells (reviewed 
by Chamberlin and Strange [42]). In Sl cells swollen in 
a low K’ saline the volume-activated efflux component 
declined steadily with time so that within 40-80 min the 
flux in the hypo-osmotic solution had reverted to the 
basal level measured under iso-osmotic conditions 
(Fig. 2). By contrast, in cells swollen in a medium de- 
signed to ‘clamp’ the volume (containing KC1 + taurine 
in place of NaCl) the high rate of taurine efflux attained 
2-3 min after the initial exposure persisted for much 
longer. This suggests that the time-dependent inactiva- 
tion of the pathway seen in the low K’ medium 
x 
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Fig. 5. Dose-response curves for the effect of 1,9-dideoxyforskolin on 
osmotically-activated taurine (0) and I- (0) efilux from Sl cells. For 
both substrates the osmotically-activated fIIux component was calcu- 
lated by subtracting the rate constant for efIIux in iso-osmotic medium 
from the maximum rate constant following reduction of the osmolality 
and is expressed as a percentage of that measured in the absence of 
inhibitors. The data are averaged from 7 different experiments. The 
curves were drawn using an equation of the form (8 con- 
trol) = (A-D)/(l + ([inhibitor]/C)a) + D, fitted to the av- 
eraged data by non-linear least squares regression. The IC, values (+ 
S.E.M.) estimated from the averaged ata were 63 f 5 and 59 f ~,BM 
for taurine and I-, respectively. 
(Figs. 1 and 2) was due largely to the cells undergoing 
RVD during the period of hypo-osmotic exposure. 
Volume-activated amino acid transport has been 
shown in a variety of different vertebrate cell-types to 
be mediated by a Na+-independent, non-saturable ‘leak 
pathway, with the properties of a pore or channel rather 
than those of a conventional carrier or transporter 
[6,15,18,22,25]. Although we cannot rule out the possi- 
bility that the inhibitors used in this study interfered 
with the regulation of volume-activated transport, 
rather than with the transport pathways themselves, the 
simplest explanation consistent with the data obtained 
here is that osmotically-activated taurine release from 
Sl cells was via the same pathway that mediated osmoti- 
cally-activated I- (Cl-) et&ix. This pathway is most 
likely a volume-activated Cl- channel. The pharmacol- 
ogical properties of this pathway are very similar to 
those of volume-activated Cl- channels elsewhere. In 
particular, they show a close resemblance to those of the 
channel associated with expression of the human mdrl 
gene product, P-glycoprotein, a 170 kDa membrane 
protein which, when expressed in mdrl-transfected cell 
lines, leads to an increased level of volume-activated Cl- 
channel activity [37,43]‘. Whether P-glycoprotein itself 
actually functions as a Cl- channel remains to be proven 
in reconstitution experiments; however, whatever the 
molecular identity of the channel associated with P- 
glycoprotein expression, it is an obvious candidate for 
the volume-activated taurine pathway. 
The hypothesis that volume-activated Cl- channels 
mediate the transport of small organic solutes such as 
amino acids has obvious implications for cell volume- 
regulation; it provides a possible explanation for the 
volume-regulatory release of a range of structurally un- 
related organic osmolytes from different cell-types. It 
might also suggest a possible role for such channels in 
the process of nutrient absorption [35]. Amino acids, 
sugars, nucleosides and many other small organic sub- 
strates are transported across the apical membranes of 
absorptive epithelia via Na’-dependent transporters. 
The coupled influx of Na+ and organic solutes causes 
cell swelling which has been shown in a number of 
different cell-types to stimulate opening of volume-acti- 
vated Cl- channels [44--47]. Such channels, if located in 
the apical membrane (as in colonic T,, cells [48]) might, 
in addition to facilitating the volume-regulatory efflux 
of Cl- and organic osmolytes, provide a high-capacity 
(albeit non-concentrative) route for the uptake of nutri- 
‘In the study which initially revealed the association between 
P-glycoprotein and a volume-activated Cl- channel, Sl cells were 
found to have little or no volume-activated Cl- channel activity [37]. 
This was clearly not the case for the cells used in the present work 
(Fig. 4). These were from the same original source [36] as those used 
in the earlier study [37], which might suggest hat the functional ex- 
pression of the channel may be dependent upon sub-culturing con- 
ditions. 
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ents when they are present in the lumen at sufficiently 
high concentrations to saturate the Na+- dependent sys- 
tems. Alternatively, or perhaps additionally, such chan- 
nels in the basolateral membrane (as in rat colon [49] or 
in MDCK cells [50]) might provide a pathway for the 
passage of absorbed nutrients into the blood. 
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